Skip to content

MNKD · NASDAQ

MannKind (MNKD) Stock Price & Fundamentals

$229.83+0.70%+$1.60End-of-day price as of Oct 9, 2026

MannKind (MNKD) closed at $229.83 on Oct 9, 2026, up 0.70% from the previous close of $228.23.

Share price, past year

1Y +5.79%

52-week range $195.14 – $243.63. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$229.83
Sep 30, 2026$241.47
Aug 31, 2026$240.67
Jul 31, 2026$224.80
Jun 30, 2026$226.17
May 29, 2026$213.59
Apr 30, 2026$211.37
Mar 31, 2026$197.32
Feb 27, 2026$205.47
Jan 30, 2026$214.04
Dec 31, 2025$212.20
Nov 28, 2025$212.81
Oct 31, 2025$212.98

Key statistics

Market cap
$71.23B
P/E (TTM)
—
EPS (TTM)
−$0.13
Revenue (TTM)
$393.63M
Net income (TTM)
−$43.61M
Shares outstanding
309.9M
Dividend yield
—
52-week range
$195.14 – $243.63

MannKind's market cap is $71.23B, based on a share price of $229.83 and 309.9M shares outstanding as of Jun 30, 2026.

Financials

MannKind reported revenue of $348.97M for fiscal 2025, up 22.23% from fiscal 2024.

MannKind earned net income of $5.86M in fiscal 2025, a net margin of 1.7%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
MannKind annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$348.97M+22.2%$5.86M1.7%$0.02$13.69M
FY2024ended Dec 31, 2024$285.50M+43.5%$27.59M9.7%$0.10$32.82M
FY2023ended Dec 31, 2023$198.96M+99.4%−$11.94M−6.0%−$0.04−$8.35M
FY2022ended Dec 31, 2022$99.77M+32.3%−$87.40M−87.6%−$0.34−$88.27M
FY2021ended Dec 31, 2021$75.44M+15.8%−$80.93M−107.3%−$0.32−$73.18M
FY2020ended Dec 31, 2020$65.14M+3.3%−$57.24M−87.9%−$0.26−$28.93M
FY2019ended Dec 31, 2019$63.04M+126.3%−$51.90M−82.3%−$0.27−$91.05M
FY2018ended Dec 31, 2018$27.86M+137.2%−$86.98M−312.2%−$0.60−$38.09M
FY2017ended Dec 31, 2017$11.75M−93.3%−$117.33M−999.0%−$1.13—
FY2016ended Dec 31, 2016$174.76M—$125.66M71.9%$1.36−$79.23M
MannKind quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$109.37M−$19.03M−$0.06
Q1 FY2026ended Mar 31, 2026$90.17M−$16.62M−$0.05
Q4 FY2025ended Dec 31, 2025$111.96M−$15.95M−$0.05
Q3 FY2025ended Sep 30, 2025$82.13M$7.99M$0.03
Q2 FY2025ended Jun 30, 2025$76.53M$668.00K$0.00
Q1 FY2025ended Mar 31, 2025$78.35M$13.16M$0.04
Q4 FY2024ended Dec 31, 2024$76.78M$7.42M$0.03
Q3 FY2024ended Sep 30, 2024$70.08M$11.55M$0.04

Company profile

Name
MannKind Corporation
Ticker
MNKD
Exchange
NASDAQ
Industry (SEC SIC)
Pharmaceutical Preparations
Headquarters
1 Casper Street, Danbury, CT 06810
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0000899460

Recent SEC filings

Frequently asked questions

What is MannKind's stock price?

MannKind (MNKD) closed at $229.83 on Oct 9, 2026, up 0.70% from the previous close of $228.23.

What is MannKind's market cap?

MannKind's market cap is $71.23B, based on a share price of $229.83 and 309.9M shares outstanding as of Jun 30, 2026.

How much revenue does MannKind make?

MannKind reported revenue of $348.97M for fiscal 2025, up 22.23% from fiscal 2024.

Does MannKind pay a dividend?

MannKind's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from MannKind Corporation's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures